Literature DB >> 22012885

Work productivity in scleroderma: analysis from the University of California, Los Angeles scleroderma quality of life study.

Manjit K Singh1, Philip J Clements, Daniel E Furst, Paul Maranian, Dinesh Khanna.   

Abstract

OBJECTIVE: To examine the productivity of patients with scleroderma (systemic sclerosis [SSc]) both outside of and within the home in a large observational cohort.
METHODS: One hundred sixty-two patients completed the Work Productivity Survey. Patients indicated whether or not they were employed outside of the home, how many days per month they missed work (employment or household work) due to SSc, and how many days per month productivity was decreased by ≥50%. Patients also completed other patient-reported outcome measures. We developed binomial regression models to assess the predictors of days missed from work (paid employment or household activities). The covariates included: type of SSc, education, physician and patient global assessments, Health Assessment Questionnaire (HAQ) disability index (DI), Functional Assessment of Chronic Illness Therapy-Fatigue, and Center of Epidemiologic Studies Depression Scale Short Form.
RESULTS: The mean age of patients was 51.8 years and 52% had limited cutaneous SSc. Of the 37% of patients employed outside of the home, patients reported missing 2.6 days per month of work and had 2.5 days per month of productivity reduced by half. Of the 102 patients who were not employed, 39.4% were unable to work due to their SSc. When we assessed patients for household activities (n = 162), patients missed an average of 8 days of housework per month and had productivity reduced by an average of 6 days per month. In the regression models, patients with lower education and poor assessment of overall health by a physician were more likely to miss work outside of the home. Patients with limited cutaneous SSc and high HAQ DI scores were more likely to miss work at home.
CONCLUSION: SSc has a major impact on productivity at home and at work. Nearly 40% of patients reported disability due to their SSc.
Copyright © 2012 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2012        PMID: 22012885      PMCID: PMC3266976          DOI: 10.1002/acr.20676

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  15 in total

Review 1.  Evidence-based management of rapidly progressing systemic sclerosis.

Authors:  Dinesh Khanna; Christopher P Denton
Journal:  Best Pract Res Clin Rheumatol       Date:  2010-06       Impact factor: 4.098

Review 2.  Measuring worker productivity: frameworks and measures.

Authors:  Dorcas Beaton; Claire Bombardier; Reuben Escorpizo; Wei Zhang; Diane Lacaille; Annelies Boonen; Richard H Osborne; Aslam H Anis; C Vibeke Strand; Peter S Tugwell
Journal:  J Rheumatol       Date:  2009-09       Impact factor: 4.666

3.  Cost-of-illness of patients with systemic sclerosis in a tertiary care centre.

Authors:  Tünde Minier; Márta Péntek; Valentin Brodszky; Adrienn Ecseki; Krisztián Kárpáti; Anna Polgár; László Czirják; László Gulácsi
Journal:  Rheumatology (Oxford)       Date:  2010-06-21       Impact factor: 7.580

4.  Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis.

Authors:  David Cella; Susan Yount; Mark Sorensen; Elliot Chartash; Nishan Sengupta; James Grober
Journal:  J Rheumatol       Date:  2005-05       Impact factor: 4.666

5.  Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale).

Authors:  E M Andresen; J A Malmgren; W B Carter; D L Patrick
Journal:  Am J Prev Med       Date:  1994 Mar-Apr       Impact factor: 5.043

6.  Worker productivity outcome measures in arthritis.

Authors:  Reuben Escorpizo; Claire Bombardier; Annelies Boonen; Johanna M W Hazes; Diane Lacaille; Vibeke Strand; Dorcas Beaton
Journal:  J Rheumatol       Date:  2007-06       Impact factor: 4.666

7.  The cost of systemic sclerosis.

Authors:  Sasha Bernatsky; Marie Hudson; Pantelis Panopalis; Ann E Clarke; Janet Pope; Sharon Leclercq; Yvan St Pierre; Murray Baron
Journal:  Arthritis Rheum       Date:  2009-01-15

8.  Does incorporation of aids and devices make a difference in the score of the health assessment questionnaire-disability index? Analysis from a scleroderma clinical trial.

Authors:  Dinesh Khanna; Philip J Clements; Arnold E Postlethwaite; Daniel E Furst
Journal:  J Rheumatol       Date:  2007-12-15       Impact factor: 4.666

9.  Discriminant validity, responsiveness and reliability of the rheumatoid arthritis-specific Work Productivity Survey (WPS-RA).

Authors:  Jane T Osterhaus; Oana Purcaru; Lance Richard
Journal:  Arthritis Res Ther       Date:  2009-05-20       Impact factor: 5.156

10.  Measurement of patient outcome in arthritis.

Authors:  J F Fries; P Spitz; R G Kraines; H R Holman
Journal:  Arthritis Rheum       Date:  1980-02
View more
  7 in total

Review 1.  Productivity Losses and Costs in the Less-Common Systemic Autoimmune Rheumatic Diseases.

Authors:  Natalie McCormick; Carlo A Marra; J Antonio Aviña-Zubieta
Journal:  Curr Rheumatol Rep       Date:  2017-10-30       Impact factor: 4.592

2.  Evaluation of a mail-delivered, print-format, self-management program for persons with systemic sclerosis.

Authors:  Janet L Poole; Betty Skipper; Cindy Mendelson
Journal:  Clin Rheumatol       Date:  2013-05-09       Impact factor: 2.980

3.  Randomized Controlled Trial to Evaluate an Internet-Based Self-Management Program in Systemic Sclerosis.

Authors:  Dinesh Khanna; Jennifer Serrano; Veronica J Berrocal; Richard M Silver; Pedro Cuencas; Sharon L Newbill; Josephine Battyany; Cynthia Maxwell; Mary Alore; Laura Dyas; Robert Riggs; Kerri Connolly; Saville Kellner; Jody J Fisher; Erica Bush; Anjali Sachdeva; Luke Evnin; Dennis W Raisch; Janet L Poole
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-02-05       Impact factor: 4.794

4.  Lower limb muscle strength is associated with functional performance and quality of life in patients with systemic sclerosis.

Authors:  Tatiana R L Lima; Fernando S Guimarães; Mara N Carvalho; Thaís L M Sousa; Sara L S Menezes; Agnaldo J Lopes
Journal:  Braz J Phys Ther       Date:  2015-03-13       Impact factor: 3.377

5.  Work Productivity and Economic Burden of Systemic Sclerosis in a Multiethnic Asian Population.

Authors:  Ling Xiang; Sandra M Y Kua; Andrea H L Low
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-03-12       Impact factor: 5.178

6.  Adipose-Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical Trial.

Authors:  Dinesh Khanna; Paul Caldron; Richard W Martin; Suzanne Kafaja; Robert Spiera; Shadi Shahouri; Ankoor Shah; Vivien Hsu; John Ervin; Robert Simms; Robyn T Domsic; Virginia Steen; Laura K Hummers; Chris Derk; Maureen Mayes; Soumya Chatterjee; John Varga; Steven Kesten; John K Fraser; Daniel E Furst
Journal:  Arthritis Rheumatol       Date:  2022-06-27       Impact factor: 15.483

7.  Fatigue Predicts Future Reduced Social Participation, not Reduced Physical Function or Quality of Life in People with Systemic Sclerosis.

Authors:  Susan L Murphy; Daniel Whibley; Anna L Kratz; Janet L Poole; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2020-09-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.